Used primarily as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system agents. Its structure supports the creation of bioactive molecules due to the presence of both a reactive hydroxymethyl group and a constrained isoxazole ring. Commonly employed in medicinal chemistry for constructing heterocyclic compounds with potential neurological activity. Also utilized in research settings for designing analogs in drug discovery programs targeting neurological disorders.